Dr. Juhana Karha, MD
What this data tells you about Dr. Karha
Dr. Juhana Karha is a cardiovascular disease in Austin, TX, with 19 years in practice. Based on federal Medicare data, Dr. Karha performed 1,413 Medicare services across 1,140 unique beneficiaries.
Between the years covered by Open Payments, Dr. Karha received a total of $144,517 from 22 pharmaceutical and/or device companies across 403 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Karha is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, high complexity | 114 | $89 | $252 |
| Office visit, established patient, complex (40-54 min) | 106 | $68 | $278 |
| Hospital follow-up visit, moderate complexity | 101 | $60 | $226 |
| Echocardiogram, transthoracic | 99 | $69 | $384 |
| Office visit, established patient (30-39 min) | 88 | $93 | $278 |
| New patient office visit (45-59 min) | 87 | $119 | $410 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 85 | $9 | $137 |
| Electrocardiogram (EKG), 12-lead | 71 | $7 | $60 |
| Routine electrocardiogram (ecg) using at least 12 leads with tracing | 57 | $5 | $31 |
| EKG interpretation and report | 56 | $6 | $32 |
| Cardiac catheterization | 52 | $186 | $1,016 |
| Regadenoson injection (Lexiscan) for heart stress test | 52 | $34 | $134 |
| Initial hospital admission, moderate complexity | 34 | $98 | $478 |
| Hospital discharge management, 30+ min | 32 | $71 | $221 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 27 | $15 | $79 |
| Initial hospital admission, high complexity | 26 | $131 | $536 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 25 | $23 | $122 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 24 | $166 | $758 |
| Ultrasound of heart, follow-up | 24 | $18 | $91 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 24 | $87 | $634 |
| Ct scan of blood vessels of chest with contrast | 21 | $55 | $292 |
| Coronary stent placement | 20 | $397 | $1,959 |
| Ultrasound of both sides of head and neck blood flow | 19 | $53 | $218 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 18 | $5 | $27 |
| Repair of left upper heart chamber with implant with review by radiologist | 17 | $565 | $2,519 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 17 | $2 | $12 |
| Anticoagulant management of patient taking warfarin | 17 | $9 | $45 |
| Ct scan of heart structure with contrast | 15 | $58 | $255 |
| Prothrombin time test (blood clotting) | 15 | $4 | $13 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 13 | $11 | $54 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 12 | $39 | $416 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) | 12 | $20 | $129 |
| Ct scan of blood vessels of neck with contrast | 11 | $64 | $266 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 11 | $16 | $84 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 11 | $9 | $53 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (77%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 4% for cardiovascular disease in TX.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Karha is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (consulting-driven, top 4%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Karha experienced with hospital follow-up visit, high complexity?
Does Dr. Karha receive payments from pharmaceutical companies?
How do Dr. Karha's costs compare to other cardiovascular diseases in Austin?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology